Obesity drugs Ozempic and Wegovy included in US price-cut talks

• Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

  The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
  
  CNBC - 5h
• 

  Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

  The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.
  
  NBC News - 7h
• 

  Medicare to Negotiate Lower Prices for Weight-Loss Drugs

  The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
  
  The New York Times - 8h

• White House says popular weight-loss drug Ozempic subject to Medicare talks

  Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.
  
  MarketWatch - 7h

• Ozempic, Wegovy on list for Medicare drug price negotiations

  The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
  
  CBS News - 7h
• 

  CMS to seek Medicare negotiations on Ozempic price

  The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...
  
  The Hill - 8h
• 

  Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges

  Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.
  
  NBC News - 3d
• 

  Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

  Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.
  
  NBC News - Jan. 9

More from Financial Times

• Tracking Ukraine’s battle against Russia in maps and charts

  A visual guide to the war
  
  Financial Times - 1h

• The Israel-Hamas war in maps and charts

  A visual guide to the conflict and its regional impact on the Middle East
  
  Financial Times - 1h

• Dale Vince did not donate £5mn to Labour to spite ex-wife, judge rules

  Former spouse of green entrepreneur awarded more than £40mn in high-profile divorce settlement
  
  Financial Times - 3h

• A long overdue ceasefire in Gaza

  Moves towards a sustainable Israeli-Palestinian peace must now begin
  
  Financial Times - 3h

• Investors better hope inflation and intangibles never meet

  Unlike physical assets, those we cannot see have never been tested by rising prices
  
  Financial Times - 4h

More in World

• 

  Live Updates: Israeli Cabinet Takes Up Gaza Cease-Fire in Final Step to Approval

  Prime Minister Benjamin Netanyahu’s office said the deal, which was approved by the security cabinet earlier Friday and is expected to get sign off from the full cabinet, could go into effect as ...
  
  The New York Times - 14m

• Last-Minute Gaza Negotiations Indicate Tough Road Ahead

  Israel and Hamas have yet to agree on a host of issues, deferring them to later stages of the multiphase cease-fire deal.
  
  The Wall Street Journal - 19m
• 

  Israel-Gaza ceasefire live: Palestinian Authority says it is ready for ‘full responsibility’ in Gaza; Israeli cabinet meets

  Mahmoud Abbas releases statement on ceasefire; Israeli cabinet meets to agree on deal as hardline security minister urges allies to stop it. Aid increase in ceasefire deal ‘is admission Israel ...
  
  The Guardian - 45m

• Inside the Gaza Deal: How a New York Real Estate Developer Took on Netanyahu and Hamas

  Envoy Steve Witkoff, carrying a message from Donald Trump, broke through the impasse in long-futile cease-fire talks.
  
  The Wall Street Journal - 54m
• 

  Half of new hospitals promised by Boris Johnson will not be built for years

  Exclusive: Labour to announce delay to many of 40 planned projects as costs spiral to estimated £30bn. At least half the 40 new hospitals promised by Boris Johnson will not be built until the ...
  
  The Guardian - 56m